vs
Side-by-side financial comparison of Spero Therapeutics, Inc. (SPRO) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $7.1M, roughly 1.8× TECHPRECISION CORP). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -20.8%, a 271.4% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -6.9%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -9.2%).
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
SPRO vs TPCS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $12.6M | $7.1M |
| Net Profit | $31.5M | $-1.5M |
| Gross Margin | — | 5.4% |
| Operating Margin | — | -19.1% |
| Net Margin | 250.7% | -20.8% |
| Revenue YoY | 24080.8% | -6.9% |
| Net Profit YoY | 250.9% | -84.4% |
| EPS (diluted) | $0.56 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.6M | $7.1M | ||
| Q3 25 | $0 | $9.1M | ||
| Q2 25 | $0 | $7.4M | ||
| Q1 25 | $12.0K | $9.5M | ||
| Q4 24 | $52.0K | $7.6M | ||
| Q3 24 | $65.0K | $8.9M | ||
| Q2 24 | $114.0K | $8.0M | ||
| Q1 24 | $140.0K | $8.6M |
| Q4 25 | $31.5M | $-1.5M | ||
| Q3 25 | $-7.4M | $825.0K | ||
| Q2 25 | $-1.7M | $-597.0K | ||
| Q1 25 | $-13.9M | $112.0K | ||
| Q4 24 | — | $-799.0K | ||
| Q3 24 | $-17.1M | $-601.0K | ||
| Q2 24 | $-17.9M | $-1.5M | ||
| Q1 24 | $-12.7M | $-5.1M |
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 14.0% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 14.3% |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | -6.3% | ||
| Q1 25 | -122758.3% | 3.9% | ||
| Q4 24 | — | -9.1% | ||
| Q3 24 | -28604.6% | -5.5% | ||
| Q2 24 | -16720.2% | -16.8% | ||
| Q1 24 | -9987.1% | -28.6% |
| Q4 25 | 250.7% | -20.8% | ||
| Q3 25 | — | 9.1% | ||
| Q2 25 | — | -8.1% | ||
| Q1 25 | -115550.0% | 1.2% | ||
| Q4 24 | — | -10.5% | ||
| Q3 24 | -26380.0% | -6.7% | ||
| Q2 24 | -15668.4% | -18.3% | ||
| Q1 24 | -9049.3% | -59.5% |
| Q4 25 | $0.56 | $-0.15 | ||
| Q3 25 | $-0.13 | $0.08 | ||
| Q2 25 | $-0.03 | $-0.06 | ||
| Q1 25 | $-0.25 | $0.01 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | $-0.32 | $-0.06 | ||
| Q2 24 | $-0.33 | $-0.16 | ||
| Q1 24 | $-0.24 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.3M | $50.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $59.0M | $8.0M |
| Total Assets | $68.9M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.3M | $50.0K | ||
| Q3 25 | $48.6M | $220.0K | ||
| Q2 25 | $31.2M | $143.0K | ||
| Q1 25 | $48.9M | $195.0K | ||
| Q4 24 | $52.9M | $165.0K | ||
| Q3 24 | $76.3M | $132.0K | ||
| Q2 24 | $63.5M | $44.8K | ||
| Q1 24 | $82.3M | $138.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $59.0M | $8.0M | ||
| Q3 25 | $26.5M | $9.1M | ||
| Q2 25 | $32.8M | $8.2M | ||
| Q1 25 | $33.8M | $8.7M | ||
| Q4 24 | $46.1M | $8.1M | ||
| Q3 24 | $65.5M | $8.9M | ||
| Q2 24 | $80.5M | $7.9M | ||
| Q1 24 | $96.2M | $7.8M |
| Q4 25 | $68.9M | $32.8M | ||
| Q3 25 | $54.2M | $33.8M | ||
| Q2 25 | $62.1M | $32.1M | ||
| Q1 25 | $77.7M | $33.5M | ||
| Q4 24 | $110.5M | $32.2M | ||
| Q3 24 | $135.2M | $35.0M | ||
| Q2 24 | $149.9M | $35.7M | ||
| Q1 24 | $167.7M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.4M | $183.0K |
| Free Cash FlowOCF − Capex | — | $-827.0K |
| FCF MarginFCF / Revenue | — | -11.7% |
| Capex IntensityCapex / Revenue | — | 14.2% |
| Cash ConversionOCF / Net Profit | -0.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.4M | $183.0K | ||
| Q3 25 | $17.4M | $-1.1M | ||
| Q2 25 | $-17.7M | $646.0K | ||
| Q1 25 | $-4.0M | $396.0K | ||
| Q4 24 | $-23.4M | $-570.0K | ||
| Q3 24 | $12.8M | $-532.0K | ||
| Q2 24 | $-18.7M | $107.0K | ||
| Q1 24 | $5.9M | $-452.0K |
| Q4 25 | — | $-827.0K | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | $-604.0K | ||
| Q1 25 | — | $-930.0K | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | $-2.0M | ||
| Q2 24 | — | $-94.0K | ||
| Q1 24 | — | $-900.0K |
| Q4 25 | — | -11.7% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | — | -8.2% | ||
| Q1 25 | — | -9.8% | ||
| Q4 24 | — | -22.9% | ||
| Q3 24 | — | -21.8% | ||
| Q2 24 | — | -1.2% | ||
| Q1 24 | — | -10.5% |
| Q4 25 | — | 14.2% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 16.9% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | — | 15.4% | ||
| Q3 24 | — | 15.9% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 5.2% |
| Q4 25 | -0.26× | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SPRO
Segment breakdown not available.
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
